$92.29
0.06% day before yesterday
NYSE, Jan 02, 10:00 pm CET
ISIN
US4577301090
Symbol
INSP

Inspire Medical Systems, Inc. Stock price

$92.27
-41.66 31.11% 1M
-38.45 29.41% 6M
+0.04 0.04% YTD
-96.92 51.23% 1Y
-159.61 63.37% 3Y
-90.18 49.43% 5Y
+67.29 269.38% 10Y
+67.29 269.38% 20Y
NYSE, Closing price Fri, Jan 02 2026
+0.04 0.04%
ISIN
US4577301090
Symbol
INSP

New AI Insights on Inspire Medical Systems, Inc. Insights AI Insights on Inspire Medical Systems, Inc.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$2.7b
Enterprise Value
$2.4b
Net debt
positive
Cash
$322.6m
Shares outstanding
29.1m
Valuation (TTM | estimate)
P/E
61.5 | 87.2
P/S
3.0 | 2.9
EV/Sales
2.7 | 2.6
EV/FCF
23.9
P/B
4.0
Financial Health
Equity Ratio
85.3%
Return on Equity
7.8%
ROCE
5.3%
ROIC
7.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$882.6m | $923.3m
EBITDA
$49.3m | $180.5m
EBIT
$36.7m | $27.4m
Net Income
$44.6m | $30.7m
Free Cash Flow
$98.8m
Growth (TTM | estimate)
Revenue
16.8% | 15.0%
EBITDA
168.4% | 323.5%
EBIT
172.1% | -24.1%
Net Income
34.8% | -42.6%
Free Cash Flow
158.7%
Margin (TTM | estimate)
Gross
84.9%
EBITDA
5.6% | 19.6%
EBIT
4.2%
Net
5.1% | 3.3%
Free Cash Flow
11.2%
More
EPS
$1.5
FCF per Share
$3.4
Short interest
16.1%
Employees
1k
Rev per Employee
$640.0k
Show more

Is Inspire Medical Systems, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Inspire Medical Systems, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Inspire Medical Systems, Inc. forecast:

19x Buy
73%
7x Hold
27%

Analyst Opinions

26 Analysts have issued a Inspire Medical Systems, Inc. forecast:

Buy
73%
Hold
27%

Financial data from Inspire Medical Systems, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
883 883
17% 17%
100%
- Direct Costs 133 133
16% 16%
15%
749 749
17% 17%
85%
- Selling and Administrative Expenses 604 604
18% 18%
68%
- Research and Development Expense 109 109
5% 5%
12%
49 49
168% 168%
6%
- Depreciation and Amortization 13 13
158% 158%
1%
EBIT (Operating Income) EBIT 37 37
172% 172%
4%
Net Profit 45 45
35% 35%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Inspire Medical Systems, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inspire Medical Systems, Inc. Stock News

Neutral
PRNewsWire
about 4 hours ago
Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline SAN FRANCISCO, Jan. 3, 2026 /PRNewswire/ -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP). The firm is urging INSP investors who suffered substantial losses to contact its at...
Neutral
GlobeNewsWire
about 23 hours ago
Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline
Neutral
Business Wire
one day ago
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming January 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Per...
More Inspire Medical Systems, Inc. News

Company Profile

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Head office United States
CEO Timothy Herbert
Employees 1,246
Founded 2007
Website www.inspiresleep.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today